Senores Pharmaceuticals' Subsidiary Receives Ukraine PIC/S GMP Certification for Mehsana Facility
Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 18 Nov 2026, 3:52 am
Senores Pharmaceuticals' Subsidiary Receives Ukraine PIC/S GMP Certification for Mehsana Facility Senores Pharmaceuticals announced that the Mehsana, Gujarat manufacturing facility of its subsidiary, Ratnatris Pharmaceuticals Private Limited, was awarded PIC/S Good Manufacturing Practices (GMP) certification by Ukraine's State Service on Medicines and Drugs Control (SMDC). The certificate was issued on 16th Nov'26 and received on 17th Nov'26. The company noted that this certification provides an expanded pathway to pursue regulatory approvals across semi-regulated markets.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding media release 路 29 Oct 2026
